Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma

Clinical trial NCT07725406 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07725406
Sponsor: Weill Medical College of Cornell University
Status: NOT_YET_RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Diffuse Large B Cell Lymphoma (DLBCL)Relapsed or Refractory Multiple Myeloma (MM)

Start date: 2026-08-01
Primary completion: 2028-08-01
Enrollment: 32

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.